US 11,304,742 · Application 16/590,804 · Granted Apr 19, 2022
US 11,304,742
Selective lung tissue ablation
Estimated expiration
December 24, 2026
87 days remaining
Earliest effective filing
Jul 28, 2006
+ 20 years
Jul 28, 2026
PTA +230d
Mar 15, 2027
TD cap (US 10,470,811)
Dec 24, 2026
Final
Dec 24, 2026
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- October 2, 2019
- Earliest effective filing
- July 28, 2006
- Issue date
- April 19, 2022
- PTA
- +230 days
- Base expiry (before PTA)
- July 28, 2026
July 28, 2006 + 20 years = July 28, 2026 + 230 PTA days = March 15, 2027
- Continuation of application 15/332,902, filed Oct 24, 2016, issued as US 10,470,811
- Continuation of application 14/033,163, filed Sep 20, 2013, issued as US 9,486,266
- Continuation of application 12/606,007, filed Oct 26, 2009, issued as US 8,568,403
- Continuation of application 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
- Continuation of application 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
- Continuation of application 12/606,007, filed Oct 26, 2009, issued as US 8,568,403
- Continuation of application 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
- Continuation of application 14/033,163, filed Sep 20, 2013, issued as US 9,486,266
- Continuation of application 12/606,007, filed Oct 26, 2009, issued as US 8,568,403
- Continuation of application 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
- PRO60/709,376 — Provisional — not used for base term
- PRO60/709,376 — Provisional — not used for base term
- PRO60/709,376 — Provisional — not used for base term
- PRO60/709,376 — Provisional — not used for base term
- PRO60/709,376 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to December 24, 2026 (earliest expiring referenced patent: US 10,470,811)
US 10,470,811· Application 15/332,902Capping patent
Selective lung tissue ablation
- Filing date
- Oct 24, 2016
- Earliest effective filing
- Jul 28, 2006
- Issue date
- Nov 12, 2019
- PTA
- +149 days
- Calculated expiration
- Dec 24, 2026
Continuation of 14/033,163, filed Sep 20, 2013, issued as US 9,486,266
Continuation of 12/606,007, filed Oct 26, 2009, issued as US 8,568,403
Continuation of 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
Continuation of 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
Continuation of 12/606,007, filed Oct 26, 2009, issued as US 8,568,403
Continuation of 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
Jul 28, 2006 + 20y + 149d PTA = Dec 24, 2026
US 9,486,266· Application 14/033,163
Selective lung tissue ablation
- Filing date
- Sep 20, 2013
- Earliest effective filing
- Jul 28, 2006
- Issue date
- Nov 8, 2016
- PTA
- +257 days
- Calculated expiration
- Apr 11, 2027
Continuation of 12/606,007, filed Oct 26, 2009, issued as US 8,568,403
Continuation of 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
Continuation of 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
Jul 28, 2006 + 20y + 257d PTA = Apr 11, 2027
US 8,568,403· Application 12/606,007
Selective lung tissue ablation
- Filing date
- Oct 26, 2009
- Earliest effective filing
- Jul 28, 2006
- Issue date
- Oct 29, 2013
- PTA
- +1038 days
- Calculated expiration
- May 31, 2029
Continuation of 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
Jul 28, 2006 + 20y + 1038d PTA = May 31, 2029
US 7,628,789· Application 11/460,860
Selective lung tissue ablation
- Filing date
- Jul 28, 2006
- Earliest effective filing
- Jul 28, 2006
- Issue date
- Dec 8, 2009
- PTA
- +412 days
- Calculated expiration
- Sep 13, 2027
Jul 28, 2006 + 20y + 412d PTA = Sep 13, 2027
US 11,304,742· Application 16/590,804(from application 16/590,804)
Selective lung tissue ablation
- Filing date
- Oct 2, 2019
- Earliest effective filing
- Jul 28, 2006
- Issue date
- Apr 19, 2022
- PTA
- +230 days
- Calculated expiration
- Mar 15, 2027
Continuation of 15/332,902, filed Oct 24, 2016, issued as US 10,470,811
Continuation of 14/033,163, filed Sep 20, 2013, issued as US 9,486,266
Continuation of 12/606,007, filed Oct 26, 2009, issued as US 8,568,403
Continuation of 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
Continuation of 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
Continuation of 12/606,007, filed Oct 26, 2009, issued as US 8,568,403
Continuation of 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
Continuation of 14/033,163, filed Sep 20, 2013, issued as US 9,486,266
Continuation of 12/606,007, filed Oct 26, 2009, issued as US 8,568,403
Continuation of 11/460,860, filed Jul 28, 2006, issued as US 7,628,789
Jul 28, 2006 + 20y + 230d PTA = Mar 15, 2027
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 16/590,804 · US 11,304,742
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 11,304,742: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US11304742Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.